Robot vs. laparoscope: which surgery is safer for early stomach cancer?
NCT ID NCT07467174
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of minimally invasive surgery for early-stage stomach cancer: a newer robotic method using fewer incisions (reduced-port) and the standard laparoscopic method. About 538 patients will be randomly assigned to one of the two surgeries. The main goal is to see if the robotic approach is as safe as the standard one, looking at complications within 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgery (reduced-port robotic subtotal gastrectomy vs. conventional laparoscopic subtotal gastrectomy)
What this could lead to
If successful, this could show that a less invasive robotic surgery is as safe as standard laparoscopic surgery for early gastric cancer, potentially leading to faster recovery and less pain.
What could go wrong
This is an early-stage comparison trial, not a test of a new drug or cure. The results may not apply to all patients or cancer stages, and the robotic approach may not prove superior.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Gastrointestinal Surgery, Department of Surgery Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••